lofexidine hydrochloride

FDA Drug Profile — Lucemyra, lofexidine hydrochloride, Lofexidine hydrochloride

lofexidine hydrochloride is listed in the FDA National Drug Code directory with 4 NDC codes, marketed under brand names including Lucemyra, lofexidine hydrochloride, Lofexidine hydrochloride. Available dosage form: tablet, film coated.

Drug Details

Generic Name
lofexidine hydrochloride
Brand Names
Lucemyra, lofexidine hydrochloride, Lofexidine hydrochloride
Application Number
NDA209229
Sponsor
USWM, LLC
NDC Codes
4
Dosage Forms
TABLET, FILM COATED
Routes
ORAL
Active Ingredients
LOFEXIDINE HYDROCHLORIDE

Indications and Usage

1 INDICATIONS AND USAGE Lofexidine tablets are indicated for mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults. Lofexidine tablets are a central alpha-2 adrenergic agonist indicated for mitigation of opioid withdrawal symptoms to facilitate abrupt opioid discontinuation in adults. ( 1 )